Youssef Shakuri Yasin

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2025
Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein.

Buthaina Jasim Yousif, Doaa Hassan Abd Alwahab, Haneen A Mohammed

|Jul 29, 2025
Impact of Esomeprazole, Ciprofloxacin and Their Combination on Cervical Cancer Cell Line Proliferation: A Focus on Heat Shock Protein 70 Modulation.

Solafa Rabi Salih, Kawakeb Najim Abdulla, Anas K Awn

|Jun 21, 2025
Synergistic Cytotoxic Impact of Linagliptin - Ciprofloxacin Combination on Cervical Cancer Cell Line: Insights into Targeting Heat Shock Protein 60.

Tiba Th Al-Mahdawi, Ali Muafaq Said, Istikrar M Hade

|Apr 30, 2025
Scrutiny of the Co-Cytotoxic Impact of Metformin-Omeprazole on the Cervical Cancer Cell Line and Their Aptitude to Target Heat Shock 60.

Rasha Kareem Khudhur, Yahiya Ibrahim Yahiya, Aqeela Hayder Majeed

|Sep 29, 2024
Antiproliferative Impact of Linagliptin on the Cervical Cancer Cell Line.

Ali Muafaq Said, Kawakeb Najim Abdulla, Nihad Hussein Ahmed

|Apr 29, 2024
The Cytotoxic Effect of Ciprofloxacin Laetrile Combination on Esophageal Cancer Cell Line.

Azal Hamoody Jumaa, Ahmed Hazem Abdulkareem, Youssef Shakuri Yasin

Pageof 1